Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243662 | SCV000314364 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000243662 | SCV000336022 | benign | not specified | 2015-10-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000988580 | SCV000373265 | likely benign | Bardet-Biedl syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Center for Pediatric Genomic Medicine, |
RCV000436346 | SCV000510963 | benign | not provided | 2016-06-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000029405 | SCV000636512 | benign | Bardet-Biedl syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000243662 | SCV000699517 | benign | not specified | 2016-01-11 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988580 | SCV001138352 | likely benign | Bardet-Biedl syndrome 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV000988580 | SCV001573508 | benign | Bardet-Biedl syndrome 1 | 2021-04-08 | criteria provided, single submitter | research | The BBS1 c.700G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: BS1, BS2. Based on this evidence we have classified this variant as Benign. |
Gene |
RCV000436346 | SCV001869034 | benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 12567324, 20498079, 27894351, 29191167, 20981092, 27884173) |
Breakthrough Genomics, |
RCV000436346 | SCV005214336 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV004562203 | SCV000033172 | pathogenic | Bardet-Biedl syndrome 1/7, digenic | 2003-03-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000988580 | SCV001454313 | benign | Bardet-Biedl syndrome 1 | 2020-09-16 | no assertion criteria provided | clinical testing |